Ciliary neurotrophic factor receptor complex (CNTF receptor complex (sometimes abbreviated as CNTFR complex))

The Ciliary neurotrophic factor receptor complex is a multi-protein cell surface signaling assembly essential for mediating the biological actions of ciliary neurotrophic factor (CNTF), a member of the interleukin‑6/gp130 cytokine family. The functional human CNTF receptor is composed of three main components: 1. CNTF-specific alpha subunit (CNTFRα): This is the ligand-binding component that confers specificity but does not itself signal intracellularly. 2. gp130: A common signal-transducing beta subunit shared by several cytokine receptors. 3. Leukemia inhibitory factor receptor beta (LIFRβ): Another signal-transducing beta subunit also used by related cytokines. Upon binding extracellular CNTF, these three components assemble into an active tripartite membrane-bound signaling unit. This triggers dimerization and conformational changes that activate associated Janus kinases (JAKs), leading to phosphorylation and nuclear translocation of STAT transcription factors—most notably STAT3—which then regulate genes involved in neuronal survival, differentiation, energy balance, and other processes. The restricted expression pattern of the alpha subunit limits physiological responses mainly to neural tissues but also allows potential therapeutic targeting in diseases involving neuronal degeneration or metabolic dysregulation.

Other names

CNTF receptorCNTFR complexCiliary neurotrophic factor signaling complex

Ligand binding (CNTF or analogs) induces sequential assembly of the tripartite membrane-bound receptor, leading to activation of intracellular JAK/STAT signaling pathways and downstream gene transcription relevant to neuronal survival, metabolism, and other functions. No widely approved small-molecule drugs directly targeting the full receptor complex are currently available.